Marilia Takada

University of Florida — United States

Medicine · Health Sciences

10h-index213citations40works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Veterinary Oncology Research(18), Sarcoma Diagnosis and Treatment(13), Histiocytic Disorders and Treatments(13), Virus-based gene therapy research(12), Tumors and Oncological Cases(11)

Publications40 total

Image-guided intensity-modulated radiation therapy for a mediastinal thymoma in a Nigerian Dwarf goat: a case report
Veterinary oncology.·2026Open Access
Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs
Veterinary and Comparative Oncology·2025Open Access
Spatial transcriptomic sequencing of fresh frozen canine osteosarcoma tumor samples
2025Open Access
Lysine-specific demethylase 1 controls key OSCC preneoplasia inducer STAT3 through CDK7 phosphorylation during oncogenic progression and immunosuppression
International Journal of Oral Science·2025· 6 citedOpen Access
Transcriptome Analysis of Canine Histiocytic Sarcoma Tumors and Cell Lines Reveals Multiple Targets for Therapy
Cancers·2025· 1 citedOpen Access
Comparison of Survival After Treatment of Presumed Intracranial Meningioma by Radiotherapy or Surgery in 285 Dogs
Journal of Veterinary Internal Medicine·2025· 5 citedOpen Access
Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial
Veterinary and Comparative Oncology·2024· 10 citedOpen Access
Identification of bbox1 as a therapeutic target in triple-negative breast cancer
UNC Libraries·2024Open Access
Successful definitive radiation treatment of refractory canine oral papillomatosis
Veterinary Radiology & Ultrasound·2024· 3 citedOpen Access
Supplementary Figure S2 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S2 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S1 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S4 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S3 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Figure S1 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Data from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Figure S2 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S3 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Table S1 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
Supplementary Figure S1 from Targeting MEK in a Translational Model of Histiocytic Sarcoma
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Vilma Yuzbasiyan‐Gurkan(28), Matti Kiupel(21), Peter Z. Schall(18), Sarah Corner(17), Jeremy M.L. Hix(16), Maciej Parys(7), Paulo Vilar Saavedra(6), Tuddow Thaiwong(5), Emmalena Gregory-Bryson(4), Ya-Ting Yang(4), Lauren A. Smyth(3), Marlee A. Richter(2), Hunter Piegols(2), Charles A. Maitz(2), Ada Naramor(2), Jishnu Rao Gutti(2), Lily Thorsen(2), Alexander I. Engleberg(2), Sirintra Sirivisoot(1), Dorela D. Shuboni‐Mulligan(1)